Kopin Corporation has announced the pricing of a $27 million public offering of common stock and pre-funded warrants. Arq, Inc. also announced the pricing of a $25 million public offering of common stock at $5.25 per share, with the offering expected to close on September 23, 2024. Arq, Inc. shares were down 14.4% pre-market following the announcement. Additionally, Fortress Biotech (FBIO) disclosed that it entered into securities purchase agreements with healthcare-focused institutional investors for the sale of 3,939,394 shares of its common stock (or pre-funded warrants) in a registered direct offering at $1.65 per share on September 19, 2024.